Actively Recruiting
Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection
Led by Hebei Medical University Fourth Hospital · Updated on 2026-02-25
200
Participants Needed
1
Research Sites
106 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a multicenter, observational real-world study, aiming to observe and evaluate the efficacy and safety of prophylactic application of Mecapegfilgrastim Injection in tumor patients after radiotherapy/chemotherapy/immunotherapy in the real world to prevent neutropenia.The subjects who met the inclusion criteria of the protocol were defined as those who needed radiotherapy/chemotherapy/immunotherapy after being diagnosed with solid malignant tumors. The researchers believed that the subjects needed to use Mecapegfilgrastim Injection for primary/secondary prevention after receiving tumor treatment.
CONDITIONS
Official Title
Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with malignant tumors confirmed by histopathology or cytology
- Age 18 years or older
- Currently receiving treatment regimens with high febrile neutropenia risk, or moderate risk with additional risk factors
- History of febrile neutropenia or dose-limiting neutropenia in prior treatment cycles
- Researchers believe the medication regimen will cause neutropenia affecting treatment
- Researchers believe the patient can benefit from the treatment
- Voluntary participation and ability to sign informed consent in person
You will not qualify if you...
- Allergy to the study drug
- Mental or neurological disorders preventing cooperation
- Pregnant or breastfeeding females
- Women of childbearing age not willing to use contraception
- Considered unsuitable for inclusion by the researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
HebeiMuFH
Shijiazhuang, Hebei, China
Actively Recruiting
Research Team
C
cheng doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here